Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma

Oncogene

Volumn 22, Issue 1, 2003, Pages 1-9

  Fukuma, Mariko ^a   Okita, Hajime ^a   Hata, Jun Ichi ^a   Umezawa, Akihiro ^a,b  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Chimeric protein; Ewing sarcoma; EWS ets; Id2

Indexed keywords

CELL RECEPTOR; CHIMERIC PROTEIN; CYCLIN D1; EWING SARCOMA PROTEIN; HELIX LOOP HELIX PROTEIN; INHIBITOR OF DIFFERENTIATION 2; ONCOPROTEIN; TRANSCRIPTION FACTOR ETS; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CARCINOGENESIS; CHILD; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; DNA MICROARRAY; EWING SARCOMA; FEMALE; GENE ACTIVATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MALE; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; TRANSACTIVATION;

ADOLESCENT; ADULT; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; DNA PRIMERS; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION PROFILING; HELIX-LOOP-HELIX MOTIFS; HUMANS; INFANT; INHIBITOR OF DIFFERENTIATION PROTEIN 2; MALE; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS; RNA-BINDING PROTEIN EWS; SARCOMA, EWING'S; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0037427070     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206055     Document Type: Article

References (37)

1. Bailly RA, Bosselut R, Zucman J, Cormier F, Delattre O, Roussel M, Thomas G and Ghysdael J. (1994). Mol. Cell Biol., 14, 3230-3241.
2. Benezra R, Davis RL, Lockshon D, Turner DL and Weintraub H. (1990). Cell, 61, 49-59.
3. Braun BS, Frieden R, Lessnick SL, May WA and Denny CT. (1995). Mol. Cell Biol., 15, 4623-4630.
4. Dauphinot L, De Oliveira C, Melot T, Sevenet N, Thomas V, Weissman BE and Delattre O. (2001). Oncogene, 20, 3258-3265.
5. Delattre O, Zucman J, Plougastel B, Desmeze C, Melot T, Peter M, Kovar H, Joubert I, de Jong P, Rouleau G, Aurias A and Thomas G. (1992). Nature, 359, 162-165.
6. Dudek H, Tantravahi RV, Rao VN, Reddy ES and Reddy EP. (1992). Proc. Natl. Acad. Sci. USA, 89, 1291-1295.
7. Edelman GM, Meech R, Owens GC and Jones FS. (2000). Proc. Natl. Acad. Sci. USA, 97, 3038-3043.
8. Gegonne A, Bosselut R, Bailly RA and Ghysdael J. (1993). EMBO J., 12, 1169-1178.
9. Iavarone A, Garg P, Lasorella A, Hsu J and Israel MA. (1994). Genes Dev., 8, 1270-1284.
10. Im YH, Kim HT, Lee C, Poulin D, Welford S, Sorensen PH, Denny CT and Kim SJ. (2000). Cancer Res., 60, 1536-1540.
11. Jeon IS, Davis JN, Braun BS, Sublett JE, Roussel MF, Denny CT and Shapiro DN. (1995). Oncogene, 10, 1229-1234.
12. Langlands K, Yin X, Anand G and Prochownik EV. (1997). J. Biol. Chem., 272, 19 785-19 793.
13. Lasorella A, Iavarone A and Israel MA. (1996). Mol. Cell. Biol., 16, 2570-2578.
14. Lasorella A, Noseda M, Beyna M, Yokota Y and Iavarone A. (2000). Nature, 407, 592-598.
15. Martinsen BJ and Bronner-Fraser M. (1998). Science, 281, 988-991.
16. Matsumoto Y, Tanaka K, Nakatani F, Matsunobu T, Matsuda S and Iwamoto Y (2001). Br. J. Cancer, 84, 768-775.
17. May WA, Arvand A, Thompson AD, Braun BS, Wright M and Denny CT. (1997). Nat. Genet., 17, 495-497.
18. Moreno CS, Beresford GW, Louis-Plence P, Morris AC and Boss JM. (1999). Immunity, 10, 143-151.
19. Nelsen B, Tian G, Erman B, Gregoire J, Maki R, Graves B and Sen R. (1993). Science, 261, 82-86.
20. Neuman T, Keen A, Zuber MX, Kristjansson GI, Gruss P and Nornes HO. (1993). Dev Biol, 160, 186-195.
21. Noguera R, Triche TJ, Navarro S, Tsokos M and Llombart BA. (1992). Lab. Invest., 66, 143-151.
22. Norton JD, Deed RW, Craggs G and Sablitzky F. (1998). Trends Cell Biol., 8, 58-65.
23. Ohno T, Ouchida M, Lee L, Gatalica Z, Rao VN and Reddy ES. (1994). Oncogene, 9, 3087-3097.
24. Pankov R, Neznanov N, Umezawa A and Oshima RG. (1994). Mol. Cell Biol., 14, 7744-7757.
25. Paulussen M, Ahrens S, Dunst J, Winkelmann W, Exner GU, Kotz R, Amann G, Dockhorn-Dworniczak B, Harms D, Muller-Weihrich S, Welte K, Kornhuber B, Janka-Schaub G, Gobel U, Treuner J, Voute PA, Zoubek A, Gadner H and Jurgens H. (2001). J. Clin. Oncol., 19, 1818-1829.
26. Peter M, Couturier J, Pacquement H, Michon J, Thomas G, Magdelenat H and Delattre O. (1997). Oncogene, 14, 1159-1164.
27. Petermann R, Mossier BM, Aryee DN, Khazak V, Golemis EA and Kovar H. (1998). Oncogene, 17, 603-610.
28. Seth A, Hodge DR, Thompson DM, Robinson L, Panayiotakis A, Watson OK and Papas TS. (1993). AIDS Res. Hum. Retroviruses, 9, 1017-1023.
29. Sorensen PH, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ and Denny CT. (1994). Nat. Genet., 6, 146-151.
30. Sugimoto T, Umezawa A and Hata J. (1997). Virchows Arch, 430, 41-46.
31. Thomas PS. (1980). Proc. Natl. Acad. Sci. USA, 77, 5201-5205.
32. Thompson AD, Braun BS, Arvand A, Stewart SD, May WA, Chen E, Korenberg J and Denny C. (1996). Oncogene, 13, 2649-2658.
33. Toretsky JA, Kalebic T, Blakesley V, LeRoith D and Helman LJ. (1997). J. Biol. Chem., 272, 30822-30827.
34. Urano F, Umezawa A, Hong W, Kikuchi H and Hata J. (1996). Biochem. Biophy. Res. Commun., 219, 608-612.
35. Urano F, Umezawa A, Yabe H, Hong W, Yoshida K, Fujinaga K and Hata J. (1998). Jpn. J. Cancer Res., 89, 703-711.
36. Wasylyk B, Wasylyk C, Flores P, Begue A, Leprince D and Stehelin D. (1990). Nature, 346, 191-193.
37. Yokota Y, Mansouri A, Mori S, Sugawara S, Adachi S, Nishikawa S and Gruss P. (1999). Nature, 397, 702-706.